Genetic Markers for Differentiating Aspirin-Hypersensitivity

다국어 초록 (Multilingual Abstract)

Aspirin-induced asthma (AIA) and aspirin-induced urticaria/ angioedema (AIU) are two major aspirin-related allergies. We summarize recent findings related to their molecular genetic mechanisms in order to identify genetic susceptibility markers for differentiating AIU and AIA. The overproduction of cysteinyl leukotriene has been suggested as a mechanism in both AIU and AIA. Increased expressionof CYSLTR1 with CYLSTR1 and CYSLTR2 polymorphisms are new findings in AIA, while the ALOX5 promoter polymorphism has been noted in AIU. An HLA study suggested that DPB1*0301 is a strong genetic marker for AIA,and that HLA DRB1*1302 and DQB1*0609 are markers for AIU susceptibility. Several single nucleotide polymorphisms (SNPs) in the promoters of EP2, TBX21, COX-2, Fc RI , and TBXA2R were associated with AIA, while an Fc RI promoter polymorphism was associated with AIU. The functional studies of the key genes involved in AIA and AIU are summarized. The identification and functional study of genetic markers for AIA and AIU susceptibility would further elucidate the pathogenic mechanisms and facilitate the development of early diagnostic markers to establish therapeutic targets.

참고문헌 (Reference)

1 "Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin- sensitive asthmatic subjects" 1025-9, amrevrespirdis1991;143

2 "Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma" 52 : 470-473, 1997

3 "Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment" 32 : 1566-1573, 2002

4 "The HLA-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin- induced urticaria" 35 : 339-344, 2005

5 "The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma" 114 : 688-689, 2004

6 "Significant association of Fc R1 promoter polymorphism with aspirin-intolerant chronic urticaria" 25 : 249-, 2005

7 "Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria/angioedema" 20 : 367-372, 2005

8 "Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma" 13 : 3203-3217, 2004

9 "Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness" 60 : 760-765, 2005

10 "Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma" 15 : 863-839, 2000

11 "Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription" 99 : 1130-1137, 1997

12 "Natural history of aspirin-induced asthma" 16 : 432-436, 2000

13 "Montelukast 10mg improves nasal function andnasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo" 59 : 289-294, 2004

14 "Montelukast 10mg improves nasal function andnasal response to aspirin in ASA-sensitive asthmatics" 59 : 289-294, 2004

15 "Leukotriene-related gene polymorphisms in patients with ASA-induced urticaria and ASA-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population" 2005

16 "Leukotriene-related gene polymorphisms in ASA- intolerant asthma: an association with a haplotype of 5-lipoxygenase" 114 : 337-344, 2004

17 "Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma" 109 : 936-942, 2002

18 "Leukotriene C4 synthase promoter polymorphism and risk of aspirin- induced asthma" 350 : 1599-1600, 1997

19 "LTC4-synthase A-444C polymorphism: lack of association with NSAID-induced isolated periorbital angioedema in a Spanish population" 87 : 506-510, 2001

20 "Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma" 166 : 301-306, 2002

21 "Improvement of aspirin- intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial" 165 : 9-14, 2002

22 "Hypersensitivity to aspirin: common eicosanoid alterations in urticariaand asthma" 113 : 771-775, 2004

23 "Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma" 113 : 771-775, 2004

24 "HLA association in aspirin-intolerant asthma: DPB1* 0301 as a strong marker in a Korean population" 113 : 562-564, 2004

25 "Genetic polymorphism of Fc R1 -109T C is associated with a susceptibility to aspirin-intolerant asthma" 25 : 248-, 2005

26 "Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma" 117 : 16-26, 2005

27 "Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma" 114 : 248-253, 2004

28 "Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma" 23 : 290-296, 2000

29 "Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients" 121 : 143-150, 2002

30 "Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients" 25 : 38-40, 1995

31 "Cutaneous reactions to aspirin and nonsteroidal anti- inflammatory drugs" 24 : 125-136, 2003

32 "Clinical characteristics of chronic urticaria with aspirin sensitivity" 25 : 194-199, 2005

33 "Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma" 35 : 585-590, 2005

34 "Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics" 15 : 483-492, 2005

35 "Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive aspirin-sensitive patients identification test (ASPITest)" 60 : 1139-1145, 2005

36 "Aspirin-sensitive asthma" 13 : 29-33, 2000

37 "Aspirin-induced asthma: advances in pathogenesis, diagnosis, andmanagement" 111 : 913-921, 2003

38 "Aspirin-induced asthma and HLA-DRB1 andHLA-DPB1 genotypes" 27 : 574-577, 1997

39 "Aspirin sensitivity and urticaria" 28 : 123-127, 2003

40 "Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs" 4 : 17-24, 2004

41 "A strong association of three genetic variants of CYSLTR1 with ASA-intolerant asthma phenotype" 115 : 134-, 2005

42 "A novel transcription factor, T-bet, directs Th1 lineage commitment" 100 : 655-669, 2000

43 "A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma" 30 : 1785-1791, 2000

44 "5' Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States" 106 : 72-76, 2000